This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTCN7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, with a ceiling value of $11,815.04, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in a unit dose of 30s. The contract has a firm fixed price pricing type and an ultimate completion date of December 6, 2024. The contract was awarded on December 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/6/25, 10:08 AM